Tylenol Delivers J&J Relief As Global 'Consumer Staples' Sales Slump
Executive Summary
J&J says Tylenol outpaced other analgesics in the first quarter as its OTC franchise grew 1.4% on a reported basis to $1.01 bn. CFO Dominic Caruso said new consumer products will add 2 points of incremental growth to the segment in 2017.
You may also be interested in...
Switches, Pediatric Products Highlight OTC Outlook In Independent Pharmacies
OTC cold and allergy product sales lead the health, wellness and beauty segment in 16,000 US independent pharmacies, says Hamacher Resource Group. Vitamins and supplements, which lead other categories in chain retail pharmacies, are the No. 2 category in independent pharmacies.
Switches, Pediatric Products Highlight OTC Outlook In Independent Pharmacies
OTC cold and allergy product sales lead the health, wellness and beauty segment in 16,000 US independent pharmacies, says Hamacher Resource Group. Vitamins and supplements, which lead other categories in chain retail pharmacies, are the No. 2 category in independent pharmacies.
Independent Pharmacies Stock Growth Opportunities In Health, Wellness And Beauty Aisles
Vitamin and supplement marketers that work closely with independent pharmacies may rise above the fray in the retail space, suggests a Hamacher Resource Group analyst. Though VMS leads other categories in pharmacy chain, it is second in independent pharmacies due to shelf space constraints.